Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.
- Resource Type
- journal article
- Source
- Journal of Clinical Oncology; 1/20/2021, Vol. 39 Issue 3, p215-226, 12p
- Subject
- Language
- ISSN
- 0732183X